Bionoid Pharma Number Of Employees vs. Cash Flow From Operations
| BINP Stock | USD 0.23 0.12 109.09% |
For Bionoid Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bionoid Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bionoid Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bionoid Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bionoid Pharma over time as well as its relative position and ranking within its peers.
Bionoid |
Bionoid Pharma Cash Flow From Operations vs. Number Of Employees Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bionoid Pharma's current stock value. Our valuation model uses many indicators to compare Bionoid Pharma value to that of its competitors to determine the firm's financial worth. Bionoid Pharma is number one stock in number of employees category among its peers. It is rated third in cash flow from operations category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bionoid Pharma's earnings, one of the primary drivers of an investment's value.Bionoid Number Of Employees vs. Competition
Bionoid Pharma is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 204,932. Bionoid Pharma adds roughly 5.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Bionoid Cash Flow From Operations vs. Number Of Employees
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Bionoid Pharma |
| = | 5 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Bionoid Pharma |
| = | (357.62 K) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Bionoid Cash Flow From Operations Comparison
Bionoid Pharma is currently under evaluation in cash flow from operations category among its peers.
Bionoid Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bionoid Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bionoid Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Bionoid Pharma's change in net profit over the period of time. It can combine multiple indicators of Bionoid Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.
Bionoid Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bionoid Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bionoid Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bionoid Pharma's important profitability drivers and their relationship over time.
Use Bionoid Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionoid Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will appreciate offsetting losses from the drop in the long position's value.Bionoid Pharma Pair Trading
Bionoid Pharma Pair Trading Analysis
The ability to find closely correlated positions to Bionoid Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionoid Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionoid Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionoid Pharma to buy it.
The correlation of Bionoid Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionoid Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionoid Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionoid Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bionoid Pharma position
In addition to having Bionoid Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Computers Thematic Idea Now
Computers
Companies that manufacture and distribute personal and business computers. The Computers theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.